01:02:07

Prolonged Exposure Therapy: 30+ Years of Study & Dissemination of Gold-Standard PTSD Psychotherapy

01:01:50

Infusing DEI in our Research Programs: An Example Studying the Social Patterning of Psychosis

01:01:58

Final Common Brain Pathways of Neuropsychiatric Symptoms

01:01:34

How Are You, Really? Taking Care of Yourself, While Taking of Others

56:26

Mechanisms for Glp1 Receptor Agonist-Induced Weight Loss: A Tale of Two Nutrient Sensors

59:35

Harmonized Healing: Treatment of Co-Occurring Posttraumatic Stress Disorder & Substance Use Disorder

57:43

Treatment of Opioid Use Disorder in the Era of Fentanyl

57:17

Examining implications of childhood adversity exposure for the treatment of mood disorders in youth

57:00

Supporting Youth in Crisis: Engaging Parents and Caregivers

59:10

Developing TMS for Alcohol Use Disorder:12 Step Journey from Preclinical Discovery to Clinical Trial

57:57

Inflammation and the central nervous system in chronic pain

01:00:33

Leveraging Interpreter Services & CLAS Standards to Improve Your Patient Care

01:05:06

The Fiction of Memory

58:23

Catatonia: epidemiology and neuropsychiatry

01:00:49

Novel neural biomarkers of mood disorder risk: replication, treatment targets and next steps

59:32

Task-Based fMRI and the Symptoms of Schizophrenia

58:42

Disruptive mood dysregulation disorder: where did it come from and what can we do about it

56:55

HSS&SC Lecture Diabetes A History of Race and Disease 20230901 120643 Meeting Recording

57:26

Prevention of Depression in Low & Middle Income Countries: NIMH-sponsored Intervention Development

57:32

Applying individual-level functional brain network approaches to Tourette syndrome

56:41

Gaining Insight into the Pathology of Early Psychosis using Brain Imaging

57:30

Psychiatry Grand Rounds Paul Holtzheimer, MD Transcranial Magnetic Stimulation for Psychiatric Dis

59:16

No Human is an Island Using Love as a Leverage for Change

01:09:44

Understanding Bias: A Necessary Component for Building Equity and Inclusion

54:23

Long-term retention on buprenorphine and the OUD Cascade of Care

56:36

Ethical Complexities in Capacity Evaluations for Pregnant Patients

57:57

Understanding Delusions Through the Predictive Coding Framework

56:15

Optimizing Telehealth for Addiction Care: COVID-19 and Beyond

49:50

Taking “social factors” into account in the mental health clinic: lessons from Brazil

57:38

Interventions for Treatment-Refractory Depression When Pharmacotherapy Hasn't Worked

57:41

Windows into Autism Through Brain, Face, and Heart

53:50

Outcome Measures in Addiction Psychiatry

52:39

Seasonal Influences on Bipolar Disorder: A Translational Perspective

55:20

Turning the tide on depression in older adults: optimal management of treatment-resistant depression

58:20

Psychosocial intervention in psychosis: conceptualizing culture in treatment of persecutory delusion

55:20

Seeds of Equity

51:25

New pharmacologic approaches to early psychosis: Taking aim at the hippocampus

58:57

Strange Bedfellows: Building Relationships between Psychiatric Emergency Services & Law Enforcement

56:35

Child Psychiatry Access: Providing a Bridge to Mental Health Care

59:23

Subjective Cognitive Decline in Older Adults

02:03:22

Befriending Your Nervous System During a Time of Turbulence and Adversity

52:12

Data driven interference in diffusion MRI

53:07

Novel Workforce and Treatments to Help Persons with Opioid Use Disorder Across the Care Continuum

59:04

Paranoia Across the Continuum from Healthy to Pathological

01:03:26

Racism from the Perspectives of an African American Man, Race Scholar, and Chief Diversity Officer

57:51

Precision Medicine Approaches to the Psychopharmacologic Treatment of Pediatric Anxiety

53:28

Mental Health During the COVID-19 Pandemic: Interplay of Individual Stressors & State Sociopolitical

56:47

Assessment and Management of Psychiatric Illness in a Patient Undergoing Heart Transplantation

57:14

Childhood irritability and neural mechanisms of frustration

59:17

Adolescent Suicide: Screening, Risk Assessment and Intervention

01:06:17

At the interface of delirium and dementia

59:05

Novel psychoactive drugs: Synthetics, designer drugs and beyond

54:30

Translating affective neuroscience to intervention: reward responsiveness and depression

54:58

Understanding the Role of the Extended Amygdala in Stress and Alcohol Use Disorder

01:00:40

Pharmacologic management of acute agitation in children and adolescents

59:46

Developing Recovery-Oriented Cognitive Therapy: Evidence-Based Journey into Recovery

58:12

The Thalamus in Psychosis

57:41

Clinico-pathological correlations and therapeutics of psychopathology in neurodegenerative disorders

59:24

Incompetent Individuals with Psychosis charged with Misdemeanors - No Place to Go

57:25

Re-envisioning psychosis care through the systemic integration of Cognitive Behavioral Therapy